| MolName | (5Z)-5-[[2-(2-morpholin-4-ylethylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C23H27N5O4S2 |
| Smiles | O=C(/C(/S1)=C/C2=C(NCCN3CCOCC3)N=C(C=CC=C3)N3C2=O)N(CC2OCCC2)C1=S |
| InChI | InChI=1S/C23H27N5O4S2/c29-21-17(14-18-22(30)28(23(33)34-18)15-16-4-3-11-32-16)20(25-19-5-1-2-7-27(19)21)24-6-8-26-9-12-31-13-10-26/h1-2,5,7,14,16,24H,3-4,6,8-13,15H2/t16-/m1/s1 |
| InChIK | GMYQGXRZUDHVQY-MRXNPFEDSA-N |
| TotalMolweight | 501.63 |
| Molweight | 501.63 |
| MonoisotopicMass | 501.150445 |
| CLogP | -0.7666 |
| CLogS | -3.627 |
| H Acceptors | 9 |
| H Donors | 1 |
| TotalSurfaceArea | 367.76 |
| Relative PSA | 0.34041 |
| PolarSurfaceArea | 144.1 |
| Druglikeness | 4.5253 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 34 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 1 |
| Rotatable Bond | 7 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Sp3Atoms | 16 |
| Symmetricatoms | 2 |
| Amides | 2 |
| Amines | 1 |
| AlkylAmines | 1 |
| BasicNitrogens | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-5-[[2-(2-morpholin-4-ylethylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-5-[[2-(2-morpholin-4-ylethylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one